News

Fluorescent marker can help surgeons remove dangerous brain tumour cells more accurately

A chemical that highlights tumour cells has been used by surgeons to help spot and safely remove brain cancer in a trial presented at the 2018 NCRI Cancer Conference. The research was carried out with patients who had suspected glioma, the disease that killed Dame Tessa Jowell, and the most common form of brain cancer. … Continue reading “Fluorescent marker can help surgeons remove dangerous brain tumour cells more accurately”

Most childhood tonsillectomies are unnecessary, study finds

A new study by founding BHP member the University of Birmingham has found that seven in every eight children who have their tonsils removed are unlikely to benefit from the operation. Researchers analysed the electronic medical records of over 1.6 million children from more than 700 UK general practices dating between 2005 and 2016. They … Continue reading “Most childhood tonsillectomies are unnecessary, study finds”

Treating the prostate with radiotherapy improves cancer survival

Treating the prostate with radiotherapy alongside standard treatment led to an 11% increase in survival for some men with advanced prostate cancer, according to a study carried out in collaboration with founding member the University of Birmingham and funded by Cancer Research UK. The findings, from one of the largest ever clinical trials for the … Continue reading “Treating the prostate with radiotherapy improves cancer survival”

National award for consultant cardiologist

William Bradlow, consultant cardiologist at BHP founding member University Hospitals Birmingham NHS Foundation Trust, recently won Cardiomyopathy UK’s Ronald Raven Award for Clinical Excellence. William won a prestigious public vote, with patients and Cardiomyopathy UK staff and volunteers nominating the healthcare professional who had made the biggest difference to cardiomyopathy patients across the country. “I’m … Continue reading “National award for consultant cardiologist”

Study confirms most effective treatment for HPV-positive throat cancer

Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to research led by BHP founder member the University of Birmingham. An abstract of the Cancer Research UK-funded study, which was carried out in collaboration with the University of Warwick, was recently delivered at the European Society for Medical … Continue reading “Study confirms most effective treatment for HPV-positive throat cancer”